|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
13
|
Resverlogix Corp.
|
Apr 20, 2021 02:37PM
|
|
Re: Veru vs Resverlogix
|
9
|
Resverlogix Corp.
|
Apr 15, 2022 10:58AM
|
|
Re: Financing-Move On
|
9
|
Resverlogix Corp.
|
May 05, 2021 01:17PM
|
|
Upcoming Presentations
|
8
|
Resverlogix Corp.
|
Oct 19, 2020 10:29AM
|
|
Bought some more at these levels.
|
8
|
Resverlogix Corp.
|
Aug 11, 2021 06:37PM
|
|
Status Update-No Eureka moment.
|
8
|
Resverlogix Corp.
|
Dec 23, 2020 09:18PM
|
|
Re: New treatment for COVID-19 discovered in human skin cells.
|
7
|
Resverlogix Corp.
|
Mar 11, 2022 09:21AM
|
|
Epigenetics
|
7
|
Resverlogix Corp.
|
Feb 12, 2022 05:13PM
|
|
Re: CBC Radio News Interview with Dr. Sweeney
|
7
|
Resverlogix Corp.
|
Feb 01, 2022 09:22AM
|
|
RVX End Game
|
7
|
Resverlogix Corp.
|
Jul 15, 2020 08:20PM
|
|
Health Canada News
|
7
|
Resverlogix Corp.
|
Apr 12, 2021 12:09PM
|
|
Re: As we appear to have a flat tire down at the registry...you then read this from Fauci!
|
7
|
Resverlogix Corp.
|
May 07, 2021 10:08AM
|
|
Re: Did you notice?
|
7
|
Resverlogix Corp.
|
May 26, 2022 10:58AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 26, 2022 09:27AM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
6
|
Resverlogix Corp.
|
Jul 25, 2020 05:32PM
|
|
Re: New exempt distribution
|
6
|
Resverlogix Corp.
|
May 06, 2021 11:25AM
|
|
Re: Deloitte
|
6
|
Resverlogix Corp.
|
May 06, 2021 01:34PM
|
|
Re: Close competitor…
|
6
|
Resverlogix Corp.
|
Oct 20, 2021 06:19PM
|
|
Re: Finance
|
6
|
Resverlogix Corp.
|
Aug 06, 2020 04:32PM
|
|
Re: RVX is warming up!
|
6
|
Resverlogix Corp.
|
Jan 25, 2022 09:26PM
|
